List of required information for application:
1. Candidate biomarker identification: Provide details about the candidate biomarker that has already been identified, including its molecular characteristics, relevance to neurological or neuromuscular disorders, and preliminary evidence supporting its potential as a biomarker.
2. Detection method technology: Describe the technology or assay used for detecting the candidate biomarker. Provide information on its development, analytical validation, and sensitivity/specificity in accurately measuring the biomarker.
3. Research and clinical need: Clearly articulate the research and clinical need for validating the candidate biomarker. Explain how the biomarker measurement will address an unmet need or improve diagnostics, prognostics, or treatment monitoring for neurological or neuromuscular disorders.
4. Context of use: Define the potential context of use for the candidate biomarker, stating how it will be utilized in clinical settings. Discuss its intended purpose, target population, and relevance to clinical decision-making or regulatory decision-making processes.
5. Study design: Outline the proposed study design for clinical validation, including the study population, sample size calculation, inclusion/exclusion criteria, and any planned interim analyses. Clearly describe the statistical methods that will be employed to assess the positive and negative predictive values of the biomarker.
6. Validation endpoints: Specify the primary and secondary endpoints that will be used to evaluate the performance of the candidate biomarker. Discuss their clinical relevance and alignment with FDA guidelines for biomarker validation.
7. Ethical considerations: Address any ethical considerations related to the proposed study, such as patient privacy, informed consent procedures, and potential risks/benefits to study participants. Provide a plan for obtaining necessary ethical approvals and ensuring compliance with relevant regulations and guidelines.
8. Investigator expertise: Highlight the qualifications and experience of the research team, specifically their expertise in biomarker research, neurological or neuromuscular disorders, clinical trial design, and data analysis. Include relevant publications or prior research that demonstrates their ability to successfully carry out the proposed study.
9. Budget justification: Provide a detailed budget breakdown, justifying the requested funds for conducting the clinical validation study. This should include costs for participant recruitment, biomarker measurement assays, data collection and analysis, and any other expenses directly related to the study.
10. Timeline: Present a feasible and realistic timeline for the proposed study, outlining key milestones and deliverables. Include estimated durations for participant recruitment, biomarker measurement, data analysis, and reporting of study results.
11. Dissemination plan: Describe
